Victoria looks to grow biomedical precinct

Latest News

The Victorian government has used CSL's announcement of its new Melbourne headquarters to launch a new study into the further development of the Parkville biomedical precinct.

The company announced yesterday its new 16-storey corporate headquarters and laboratories will be constructed at 645 Elizabeth Street on the northern edge of Melbourne’s CBD.

It will be located within the biomedical precinct that also houses a range of research institutes, including the University of Melbourne, the Walter and Eliza Hall Institute of Medical Research, the Doherty Institute for Infectious Disease, The Murdoch Children’s Research Institut and the Victorian Comprehensive Cancer Centre.

At the same time, the Victorian government announced a new partnership with the University of Melbourne that will investigate the world's leading innovation precincts, including in Boston, Tel Aviv and the MaRS Discovery District of Toronto, and the potential opportunities for Parkville.